THE PURPOSE OF THE STUDY IS TO EVALUATE WHETHER THE USE OF C-PULSE™ AS TREATMENT FOR PATIENTS IN MODERATE TO SEVERE HEART FAILURE (HF) IS ASSOCIATED WITH REASONABLE ASSURANCE OF SAFETY AND PERFORMANCE: